Bleakley Financial Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
+35,715
New +$154K ﹤0.01% 940
2025
Q1
– Sell
-34,888
Closed -$39.1K – 850
2024
Q4
$39.1K Sell
34,888
-332
-0.9% -$283 ﹤0.01% 1028
2024
Q3
$33.4K Sell
35,220
-4,294
-11% -$5.42K ﹤0.01% 1009
2024
Q2
$62.4K Buy
39,514
+4,310
+12% +$6.26K ﹤0.01% 969
2024
Q1
$51K Buy
35,204
+959
+3% +$1.38K ﹤0.01% 965
2023
Q4
$45.9K Sell
34,245
-10,731
-24% -$12.6K ﹤0.01% 930
2023
Q3
$63.9K Buy
44,976
+1,785
+4% +$2.53K ﹤0.01% 848
2023
Q2
$49.7K Buy
43,191
+4,121
+11% +$4.87K ﹤0.01% 902
2023
Q1
$41.4K Buy
39,070
+1,463
+4% +$2.11K ﹤0.01% 881
2022
Q4
$57.2K Buy
+37,607
New +$64.7K ﹤0.01% 837

Other funds holding PGEN

Bleakley Financial Group's PGEN Position: Q2 2026 in Review

Bleakley Financial Group opened a new position in Precigen (PGEN) in Q2 2026: 35,715 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings. This is a return to the name: Bleakley Financial Group previously reported a position in PGEN as recently as Q4 2024.

Bleakley Financial Group first reported a position in PGEN in Q4 2022 and has held it in 10 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Bleakley Financial Group held 35,715 shares of Precigen worth $204K as of Q2 2026.
  • Precigen was a new Bleakley Financial Group position in Q2 2026.
  • Precigen made up ﹤0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #940 holding.
  • Bleakley Financial Group first reported a position in Precigen in Q4 2022 and has held it in 10 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.